Sector

Healthcare & Medical

Live opportunities

492

Largest live: £4.3bn

A well-supplied UK & EU sector, led by NHS ENGLAND, most recent listing today.

United Kingdom + 5 moreAvg value £23.9m+55% · 30 days

Clinical services, medical equipment, pharmaceuticals, NHS contracts, and health research.

Live opportunities

492

Largest live: £4.3bn

Activity, last 12 months

7K published

2025-10Peak: 2026-06 · 1K2026-11

Sector brief

4 fields

Live now
492
Opportunities open today
Total on record
13K
Across all statuses
Total value (£ only)
£311bn
Avg £23.9m
30-day momentum
+55%
Last published -18 days ago

Opportunities

492 on record

Germany

Open House Discount Contracts for Denosumab (Xgeva)

This contract opportunity involves the establishment of non-exclusive discount agreements for the pharmaceutical product Denosumab, marketed as Xgeva, in accordance with German social law. The contracts will be valid from July 1, 2025, to June 30, 2027, and suppliers can enter into agreements at any

AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

Published 18 May 2025

Germany

Open House Discount Contracts for Somatropin

This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical product Somatropin, classified under ATC code H01AC01. The contracts will be valid from July 1, 2025, to June 30, 2027, and suppliers can enter into contracts at any time during this perio

AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

Published 18 May 2025

Germany

Axitinib Drug Supply Contracts

This contract opportunity involves the establishment of non-exclusive discount agreements for finished pharmaceuticals containing the active ingredient Axitinib (ATC: L01EK01) under an 'open-house model'. All eligible and interested pharmaceutical companies or consortia are invited to enter into or

AOK SACHSEN ANHALT

Published 18 May 2025

Germany

Framework Agreement for Pharmaceuticals in Germany

This announcement is not for the awarding of a public contract as defined by the Public Procurement Directive (2014/24/EU) or competition law. It aims to inform interested pharmaceutical companies broadly and is published in the Supplement to the Official Journal of the European Union. The term 'Ope

BARMER PROCUREMENT AND AWARD

Published 14 May 2025

Germany

Germany – Non-Exclusive Discount Agreements for Pharmaceuticals

The KKH (Kaufmännische Krankenkasse) aims to establish non-exclusive discount agreements with all suitable pharmaceutical companies for the specified active ingredients under the Open-House procedure as per § 130a Abs. 8 SGB V. This process allows all eligible and interested pharmaceutical companies

KKH COMMERCIAL HEALTH INSURANCE

Published 14 May 2025

Germany

Germany – Pharmaceuticals – Non-exclusive Discount Agreements for Active Ingredients

The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the active ingredient(s) under Section 130a (8) of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interested pharmaceutica

KKH COMMERCIAL HEALTH INSURANCE

Published 12 May 2025

Germany

Germany – Pharmaceutical Discounts Agreement

The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a (8) of the Social Code Book V, using an 'Open-House' procedure. This process allows all eligible and interested pharmaceutical

KKH COMMERCIAL HEALTH INSURANCE

Published 11 May 2025

Germany

Germany – Pharmaceuticals – Non-Exclusive Discount Agreements for Active Ingredients

The KKH (Kaufmännische Krankenkasse) aims to establish discount agreements with all suitable pharmaceutical companies for the active ingredient(s) under Section 130a, Paragraph 8 of the Social Code Book V, through an 'Open-House' procedure. This process allows all eligible and interested pharmaceuti

KKH COMMERCIAL HEALTH INSURANCE

Published 6 May 2025

Germany

Open-House Discount Contracts for Trastuzumab in Germany

This contract opportunity involves the establishment of non-exclusive discount agreements for the drug Trastuzumab, classified under ATC code L01FD01, in the regions of Lower Saxony, Bremen, and Saxony-Anhalt. The focus is on parenteral preparations made from finished medicinal products for oncology

AOK LOWER SAXONY THE HEALTH FUND

Published 27 Apr 2025

United Kingdom

Occupational Health Services Procurement

The Crown Commercial Service (CCS) is establishing a Dynamic Purchasing System (DPS) to procure Occupational Health and Related Services. This includes services such as occupational health assessments, employee assistance programs, managed services, eyecare services, and hearing services. The DPS is

est.£220,000,000CROWN COMMERCIAL SERVICE

Published 30 Aug 2024